Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan.
Clinical trial NCT04626505 · COMPLETED
Trial details
- NCT number
- NCT04626505
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-22
- Primary completion
- 2021-08-03
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.